Pulmonary Function Decline in Very Early Diagnosis of Systemic Sclerosis: A Retrospective Longitudinal Single‐Center Study

Key Points

• To assess pulmonary function decline in patients with very early systemic sclerosis and its potential markers.
• Conducted a retrospective longitudinal analysis at a single center.
• Evaluated baseline DLco/SB levels in patients with VEDOSS.
• Monitored pulmonary function over time to identify possible declines.
• Identified baseline DLco/SB <70% as a marker for disease progression.
• Observed subtle declines in pulmonary function even among stable patients.

Abstract